May 22, 2020 / 12:19 PM / 5 days ago

BRIEF-T2 Biosystems Expects Demand For T2SARS-COV-2 Test Upon Being Made Commercially Available For Clinical Use

May 22 (Reuters) - T2 Biosystems Inc:

* T2 BIOSYSTEMS - ANTICIPATES DEMAND FOR THE T2SARS-COV-2 TEST UPON BEING MADE COMMERCIALLY AVAILABLE FOR CLINICAL USE

* T2 BIOSYSTEMS INC - CURRENTLY HAS RESOURCES TO MANUFACTURE UP TO 100,000 TESTS PER MONTH

* T2 BIOSYSTEMS - SUBJECT TO SECURING ADDITIONAL NON-DILUTIVE FUNDING, ESTIMATES CO COULD POTENTIALLY RAMP TO ABOUT 1 MILLION TESTS PER MONTH

* T2 BIOSYSTEMS INC - ANTICIPATES SHIPPING FIRST TESTS TO U.S. CUSTOMERS FOR CLINICAL USE AS EARLY AS END OF JUNE Source text for Eikon: [ID: bit.ly/36lzA3y] Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below